Nihon Kohden Analysis (June 2026) | Price Development & Price Target

Nihon Kohden

TSE:6849

¥ 1.447,00

+ ¥4,00 (0,28%)

1.447,00 ¥

+¥4,00 (0,28%)

End-of-day quote: 05/29/2026

Nihon Kohden Stock Value

The analyst rating for TSE:6849 is currently Outperform.

Outperform

Nihon Kohden Company Info

EPS Growth 5Y

9,06%

Market Cap

¥231,48 B

Long-Term Debt

¥0,00 B

Quarterly earnings

07/31/2026

Dividend

¥32,12

Dividend Yield

2,22%

Founded

1951

Industry

Health Care

Country

Japan

Website

Nihon Kohden

ISIN Number

JP3706800004

Website

http://www.nihonkohden.com

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

¥1.880,00

29.92%

Last Update: 05/20/2026

Analysts: 8

Highest Price Target ¥2.700,00

Average Price Target ¥1.880,00

Lowest Price Target ¥1.700,00

In the last five quarters, Nihon Kohden’s Price Target has fallen from ¥2.806,57 to ¥2.378,57 - a -15,25% decrease. Eight analysts predict that Nihon Kohden’s share price will increase in the coming year, reaching ¥1.880,00. This would represent an increase of 29,92%.

Top growth stocks in the health care sector (5Y.)

What does Nihon Kohden do?

Nihon Kohden Corporation engages in development, manufacturing, sale, maintenance, and consultation of medical electronic equipment, and related systems and products in Japan, Americas, Europe, rest of Asia, and internationally. Business Segments The company operates through the following segments Physiological Measuring Equipment, Patient Monitoring Systems, Treatment Equipment, Medical Support Systems, and In-vitro Diagnostic Equipment. Physiological Measuring Equipment The Physiological M...

Business Segments

The company operates through the following segments Physiological Measuring Equipment, Patient Monitoring Systems, Treatment Equipment, Medical Support Systems, and In-vitro Diagnostic Equipment.

Physiological Measuring Equipment

The Physiological Measuring Equipment segment engages in the development and manufacturing of devices such as electrocardiographs, electroencephalographs, and polygraphs, particularly for use in catheterization laboratories (Cath-labs). This segment aims to provide healthcare professionals with the tools necessary for accurate physiological monitoring and diagnostics.

Patient Monitoring Systems

The Patient Monitoring Systems segment focuses on creating bedside and central monitoring systems that facilitate real-time tracking of patient vitals. This segment is crucial in acute care settings where continuous monitoring is essential for patient safety and timely medical interventions.

Treatment Equipment

The Treatment Equipment segment engages in the production of critical medical devices, including defibrillators, automated external defibrillators, ventilators, and pacemakers. These devices are vital for emergency care and ongoing treatment of patients with severe health conditions.

Medical Support Systems

The Medical Support Systems segment includes diagnostic and clinical information systems that streamline healthcare processes and enhance data management in clinical settings. This segment plays a significant role in improving the efficiency of healthcare delivery.

In-vitro Diagnostic Equipment

The In-vitro Diagnostic Equipment segment provides hematology and clinical chemistry analyzers that support laboratory diagnostics. These tools are essential for accurate disease diagnosis and monitoring patient health.

Business Strategy

The company business strategy revolves around innovation, operational excellence, and strategic partnerships aimed at sustainable growth in the healthcare sector. The company also invests heavily in research and development (R&D) to foster innovation and meet the evolving needs of healthcare providers and patients. By focusing on advanced medical technologies, the company aims to maintain its competitive edge in the market. The company actively seeks acquisitions and collaborations with technology firms and healthcare organizations to enhance its product offerings and expand its market reach. This approach not only strengthens its innovation pipeline but also improves access to healthcare solutions globally. Additionally, the company emphasizes sustainability in its operations, aligning its initiatives with broader health outcomes and community needs, thereby reinforcing its commitment to corporate social responsibility.

Products and Services

The company offers a diverse range of products designed to meet the needs of healthcare professionals and patients. Key products include physiological measuring equipment such as electrocardiographs and electroencephalographs, which are vital for monitoring heart and brain activity. The company also provides advanced patient monitoring systems that ensure real-time tracking of vital signs, enhancing patient safety. Additionally, its treatment equipment, including defibrillators and ventilators, is crucial for emergency medical interventions. The in-vitro diagnostic equipment segment features hematology and clinical chemistry analyzers that facilitate laboratory diagnostics, providing accurate results for disease management. The breadth of these product offerings underscores the company's commitment to improving health outcomes through innovative medical technology.

The company provides a range of services that support healthcare institutions and professionals. These services include maintenance and consultation for medical electronic equipment, ensuring that devices operate efficiently and effectively. The company also offers training and support for healthcare personnel to maximize the use of its products, thus enhancing patient care. By providing comprehensive services alongside its products, the company reinforces its commitment to quality healthcare delivery and supports healthcare providers in their mission to improve patient outcomes.

Geographical Markets Served

The company operates in several geographical markets, including Japan, the Americas, Europe, and the rest of Asia. This global presence allows the company to tailor its products and services to meet the specific healthcare needs and regulatory requirements of each region, optimizing its impact on healthcare systems worldwide.

Customers

The company serves a diverse customer base that includes hospitals, clinics, diagnostic laboratories, and healthcare providers. The company’s products are utilized by governments and healthcare institutions globally, catering to both institutional and individual patient needs. This broad customer spectrum highlights the company’s commitment to addressing various healthcare challenges across different demographics.

Sales and Marketing Channels

The company employs a multifaceted sales and marketing strategy to reach its customers effectively. The company utilizes direct sales forces, online marketing, and participation in medical congresses and professional seminars to promote its products. Sales representatives play a crucial role in building relationships with healthcare professionals and institutions, ensuring that customers receive personalized support. Additionally, partnerships with distributors and wholesalers enhance the company’s market presence, making its products readily available across various regions.

History

Nihon Kohden Corporation was founded in 1951. The company was incorporated in 1951.

Nihon Kohden Questions and Answers

Which sectors generate sales and which are the top 3 markets?

**medical technology industry:** main revenue source **patient monitoring systems:** 40% **cardiological products:** 30% **neurological products:** 20% **top 3 markets:** 1. **japan:** 50% 2. **usa:** 25% 3. **europe:** 15% nihon kohden corporation generates the majority of its revenue fr...

At which locations are the company’s products manufactured?

**production sites:** japan, usa, china nihon kohden corporation mainly produces its products in japan, where the company's headquarters are also located. in addition, the company has production facilities in the usa and china to better serve the demand in international markets. this geographi...

What strategy does Nihon Kohden pursue for future growth?

**revenue growth:** 6.5% (2025) **research & development:** 8% of revenue (2025) nihon kohden corporation pursues a strategy that heavily focuses on innovation and technological development. a key component of this strategy is increasing investments in research and development, which accounted...

Which raw materials are imported and from which countries?

**main raw materials:** electronic components, metals, plastics **countries of origin:** china, japan, south korea, germany nihon kohden corporation is a leading manufacturer of medical devices and technologies. the company mainly imports electronic components that are essential for the production...

How strong is the company’s competitive advantage?

**market share in japan:** approximately 30% (2025) **research & development (r&d) expenses:** 8.5% of revenue (2025) **gross margin:** 48% (2025) nihon kohden corporation has a significant competitive advantage, especially in the japanese market, where the company holds a market share...

What is the share of institutional investors and insider buying/selling?

**institutional investor share:** estimated 45% (2026) **insider buys/sells:** no significant transactions in the last year the institutional investor share in nihon kohden corporation is approximately 45%. this demonstrates the confidence of institutional investors in the long-term stability and...

What percentage market share does Nihon Kohden have?

**market share of nihon kohden corporation:** estimated 5-7% (2026) **top competitors and their market shares:** 1. **medtronic plc:** 15-18% 2. **philips healthcare:** 10-12% 3. **ge healthcare:** 8-10% 4. **siemens healthineers:** 7-9% 5. **fujifilm holdings corporation:** 5-7% 6. **nihon kohden...

Is Nihon Kohden stock currently a good investment?

**revenue growth:** 8.2% (2025) **profit growth:** 6.5% (2025) **research & development expenses:** 10% of revenue (2025) in 2025, nihon kohden corporation recorded a revenue growth of 8.2%, indicating strong demand for their medical devices and solutions. the profit growth of 6.5% during the s...

Does Nihon Kohden pay a dividend – and how reliable is the payout?

**dividend yield:** 2.5% (estimated for 2026) **dividend history:** continuous payout over the last 5 years nihon kohden corporation has pursued a stable dividend policy in recent years. the company is known for regularly distributing dividends to its shareholders. the estimated dividend yield...

New support ticket

Explore

Nihon Kohden Stock Value

Nihon Kohden Company Info

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Nihon Kohden do?

Nihon Kohden Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

New support ticket

Explore

Nihon Kohden Stock Value

Nihon Kohden Company Info

Analyst Price Target The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Nihon Kohden do?

Nihon Kohden Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.